Literature DB >> 10526151

Direct evidence of cytoplasmic delivery of PKC-alpha, -epsilon and -zeta pseudosubstrate lipopeptides: study of their implication in the induction of apoptosis.

K Thiam1, E Loing, D Zoukhri, C Rommens, R Hodges, D Dartt, C Verwaerde, C Auriault, H Gras-Masse, C Sergheraert.   

Abstract

Protein kinases C (PKC) are serine/threonine kinase enzymes involved in the mechanism of cell survival. Their pseudosubstrate sequences are autoinhibitory domains, which maintain the enzyme in an inactive state in the absence of allosteric activators, thus representing an attractive tool for the modulation of different PKC isoforms. Here, we report the use of palmitoylated modified PKC-alpha, -epsilon, and -zeta pseudosubstrate peptides, and determine their intracellular distribution together with their respective PKC isoenzymes. Finally, we propose that the differential distribution of the peptides is correlated with a selective induction of apoptosis and therefore argues for different involvement of PKC isoforms in the anti-apoptotic program.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526151     DOI: 10.1016/s0014-5793(99)01240-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Peptides modified by myristoylation activate eNOS in endothelial cells through Akt phosphorylation.

Authors:  Karina Krotova; Hanbo Hu; Shen-Ling Xia; Leonid Belayev; Jawaharlal M Patel; Edward R Block; Sergey Zharikov
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

2.  The p75NTR signaling cascade mediates mechanical hyperalgesia induced by nerve growth factor injected into the rat hind paw.

Authors:  A Khodorova; G D Nicol; G Strichartz
Journal:  Neuroscience       Date:  2013-10-01       Impact factor: 3.590

3.  Mechanisms of peptide amphiphile internalization by SJSA-1 cells in vitro.

Authors:  Dimitris Missirlis; Htet Khant; Matthew Tirrell
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.